A New Era in Continuous Glucose Monitoring: Food and Drug Administration Creates a New Category of Factory-Calibrated Nonadjunctive, Interoperable Class II Medical Devices

DIABETES TECHNOLOGY & THERAPEUTICS

MARY ANN LIEBERT, INC

1. Medtronic
2. Roche
3. Merck
4. Lexicon
5. Novo Nordisk
6. Sanofi
7. Mannkind
8. Senseonics
9. Zealand
10. Eli Lilly
11. Dario
12. NCI
13. T1D Exchange
14. NIDDK
15. JDRF
16. Animas
17. Dexcom